PubRank

M E Kaplan

Author PubWeight™ 46.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods 1974 6.54
2 Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982 3.82
3 Cryoglobulinemia in infectious mononucleosis: quantitation and characterization of the cryoproeins. J Lab Clin Med 1968 1.23
4 Frequent association of IgMlambda with crystalline inclusions in chronic lymphatic leukemic lymphocytes. N Engl J Med 1973 1.20
5 Antinuclear antibodies in infectious mononucleosis. Lancet 1968 1.17
6 Immunochemical studies on blood groups. XXXIII. The effects. of alkaline borohydride and of alkali on blood group A, B, and H substances. Biochemistry 1965 1.12
7 Studies on human antibodies. IV. Purification and properties of anti-A and anti-B obtained by absorption and elution from insoluble blood group substances. J Exp Med 1966 1.09
8 Human monocyte and macrophage modulation of lymphocyte proliferation. Cell Immunol 1979 1.07
9 Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma. Cancer Genet Cytogenet 1984 1.06
10 Cell-cell interaction in erythropoiesis. Role of human monocytes. J Clin Invest 1978 1.06
11 From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Semin Hematol 1997 1.05
12 Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA. J Immunol 1972 1.02
13 Hemoglobin Andrew-Minneapolis alpha 2 A beta 2 144 Lys leads to Asn: a new high-oxygen-affinity mutant human hemoglobin. Blood 1974 1.00
14 Red-cell-membrane polypeptide aggregates in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease. A clue to the mechanism of hemolysis. N Engl J Med 1979 0.98
15 Membrane polypeptide aggregates in glucose 6-phosphate dehydrogenase-deficient and in vitro aged red blood cells. J Lab Clin Med 1978 0.97
16 Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity. Int J Cancer 1978 0.95
17 Maternal and paternal lineages of the Samaritan isolate: mutation rates and time to most recent common male ancestor. Ann Hum Genet 2003 0.95
18 In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol 1982 0.94
19 The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase. Blood 1988 0.94
20 Human monocyte-induced tumor cell cytotoxicity. Blood 1978 0.93
21 Characterization and comparison of human monocyte- and macrophage-induced tumor cell cytotoxicity. J Lab Clin Med 1979 0.93
22 Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost 1986 0.88
23 Leukocytosis and large cell lung cancer. A frequent association. Cancer 1987 0.87
24 Immune mechanisms for destruction of erythrocytes in vivo. I. The effect of IgG rabbit antibodies on rat erythrocytes. Transfusion 1967 0.85
25 Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia. Cancer Treat Rep 1979 0.85
26 Serum anti-gamma-G globulin factors in paroxysmal nocturnal hemoglobinuria. Blood 1966 0.84
27 Cryptococcal meningitis with false-positive cytology in the CSF. Use of T-cell rosetting to exclude meningeal lymphoma. JAMA 1978 0.84
28 Cell-cell interaction in erythropoiesis. Prog Hematol 1979 0.83
29 Treatment of polycythemia vera with hydroxyurea. Am J Hematol 1984 0.83
30 Heterogeneity of human lymphocyte Fc receptors. II. Relationship to antibody-dependent, cell-mediated cytotoxicity. Clin Exp Immunol 1978 0.82
31 The importance or red cell B12 and folate levels after partial gastrectomy. Am J Clin Nutr 1974 0.81
32 Capping of peripheral blood lymphocyte C3 receptors in chronic lymphocytic leukemia: relationship to chemotherapy. Int J Cancer 1981 0.81
33 Erythrocyte-bound C5 and C6 in autoimmune hemolytic anemia. J Immunol 1971 0.79
34 Effects of shortened erythropoietin exposure on sheep marrow cultures. Br J Haematol 1981 0.79
35 Heterogeneity of human lymphocyte Fc receptors. I. Differential susceptibility to proteolysis. Clin Exp Immunol 1978 0.78
36 Long-term management of polycythemia vera with hydroxyurea: a progress report. Semin Hematol 1986 0.78
37 Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A. J Clin Invest 1972 0.78
38 Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 1986 0.77
39 Human peripheral blood erythroid burst forming unit (BFU(E)): evidence against T-lymphocyte requirement for proliferation in vitro. Exp Hematol 1980 0.77
40 Severe thrombocytopenia in an acquired immunodeficiency syndrome patient associated with pentamidine-dependent antibodies specific for glycoprotein IIb/IIIa. Blood 1993 0.77
41 G-6-PD Long Prairie: a new glucose-6-phosphate dehydrogenase mutant exhibiting normal sensitivity to inhibition by NADPH and accompanied by nonspherocytic hemolytic anemia. Blood 1977 0.77
42 Defective expression of T cell antigens in chronic lymphocytic leukaemia: relationship to T cell dysfunction. Br J Haematol 1984 0.76
43 Establishment and characterization of a subclone (U-937-AG) from a permanent human monocyte cell line. Leuk Res 1984 0.75
44 Heterogeneity of human lymphocyte Fc receptors: studies using heat-aggregated and antigen-complexed IgG from human, rabbit, guinea pig, horse and goat. Comp Immunol Microbiol Infect Dis 1982 0.75
45 Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols. Am J Hematol 1984 0.75
46 Evidence for gastric intrinsic factor in the eel (Anguilla rostrata). Proc Soc Exp Biol Med 1969 0.75
47 The kinetic properties of the ecto-ATPase of human peripheral blood lymphocytes and of chronic lymphatic leukemia cells. Blood 1983 0.75
48 Non-Hodgkin's lymphoma after treatment for Hodgkin's disease. Oncology 1982 0.75
49 Complement-fixing and hemolytic properties of certain erythrocyte autoantibodies. J Lab Clin Med 1971 0.75
50 Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agents. J Immunol 1980 0.75
51 The bacteria(B)--antibody(A)--complement(C) (BAC) rosette method for detecting C3 receptors (R): binding specificity and capping of human peripheral blood lymphocyte C3r. Cell Immunol 1980 0.75
52 Lymphocytotoxic T lymphocytes in a patient with B-chronic lymphocytic leukemia and pure red cell aplasia. Leuk Res 1985 0.75
53 Two mechanisms of erythrocyte destruction in penicillin-induced hemolytic anemia. N Engl J Med 1972 0.75
54 Effects of thiols on sheep erythrocytes resulting in enhanced rosette formation with human T lymphocytes. Proc Soc Exp Biol Med 1976 0.75
55 Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. Leukemia 1992 0.75
56 Defective T cell responsiveness in chronic lymphocytic leukemia: analysis of activation events. Blood 1986 0.75